ISO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ISO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. IsoPlexis's Net Income for the three months ended in Dec. 2022 was $-33.21 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2022 was $-106.00 Mil.
Net Income is linked to the most popular Earnings per Share (Diluted) number. IsoPlexis's Earnings per Share (Diluted) for the three months ended in Dec. 2022 was $-0.84.
The historical data trend for IsoPlexis's Net Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IsoPlexis Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Net Income | -13.63 | -23.26 | -81.57 | -106.00 |
IsoPlexis Quarterly Data | |||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | |
Net Income | Get a 7-Day Free Trial | -25.26 | -28.73 | -25.61 | -18.46 | -33.21 |
Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.
Net Income
= Revenue
- Cost of Goods Sold
- Selling, General, & Admin. Expense
- Research & Development
- Depreciation, Depletion and Amortization
- Interest Expense
- Non Operating Income (NRI) - Tax Expense + Others
= EBITDA
- Depreciation, Depletion and Amortization
- Interest Expense
- Non Operating Income (NRI) - Tax Expense + Others
= Operating Income
- Interest Expense
- Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others
IsoPlexis's Net Income for the fiscal year that ended in Dec. 2022 is calculated as
Net Income | (A: Dec. 2022 ) | ||||||
= | Pre-Tax Income | + | Tax Provision | + | Net Income (Discontinued Operations) | + | Others |
= | -105.997 | + | 0 | + | 0 | + | 0 |
= | -106.00 |
IsoPlexis's Net Income for the quarter that ended in Dec. 2022 is calculated as
Net Income | (Q: Dec. 2022 ) | ||||||
= | Pre-Tax Income | + | Tax Provision | + | Net Income (Discontinued Operations) | + | Others |
= | -33.212 | + | 0 | + | 0 | + | 0 |
= | -33.21 |
Net Income for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-106.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IsoPlexis (NAS:ISO) Net Income Explanation
Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:
IsoPlexis's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2022 is calculated as
Earnings per Share (Diluted) (Q: Dec. 2022 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Diluted Average) |
= | (-33.212 | - | 0) | / | 39.590 | |
= | -0.84 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
EPS is most useful for companies that have:
A predictable businessThe dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
Thank you for viewing the detailed overview of IsoPlexis's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Nachum Shamir | director | 12212 TECHNOLOGY BLVD, AUSTIN TX 78727 |
John Strahley | officer: Chief Financial Officer | 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405 |
Sean Mackay | director, officer: Chief Executive Officer | 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405 |
Rew Richard W. Ii | officer: SVP, GC & Secretary | 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735 |
James R Heath | director | C/O ISOPLEXIS, 35 NE INDUSTRIAL RD, BRANFORD CT 06405 |
Michael Egholm | director | 1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110 |
Siddhartha Kadia | director | 7475 LUSK BOULEVARD, SAN DIEGO CA 92121 |
Jason W. Myers | director | C/O ARCHERDX, INC., 2477 55TH STREET, SUITE 202, BOULDER CO 80301 |
John G. Conley | director | 396 GREAT MEADOWS RD, CONCORD MA 01742-1803 |
Gregory P. Ho | director, 10 percent owner | C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022 |
Peter Siesel | officer: Chief Commercial Officer | 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405 |
Jing Zhou | officer: Chief Scientific Officer | 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405 |
Rajesh T. Khakhar | officer: VP, Finance | 35 NORTH INDUSTRIAL ROAD, BRANFORD CT 06405 |
Northpond Capital Gp, Llc | 10 percent owner | 4 BRATTLE STREET, FLOOR 3, CAMBRIDGE MA 02138 |
Perceptive Life Sciences Master Fund Ltd | 10 percent owner | C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 02-16-2022
By GuruFocusNews GuruFocusNews • 05-11-2022
By GuruFocusNews GuruFocusNews • 07-10-2022
By PRNewswire PRNewswire • 03-02-2023
By Tiesvg Tiesvg • 12-21-2022
By PurpleRose PurpleRose • 08-23-2022
By GuruFocusNews GuruFocusNews • 06-30-2022
By PRNewswire PRNewswire • 02-03-2023
By GuruFocusNews GuruFocusNews • 06-10-2022
By GlobeNewswire GlobeNewswire • 12-21-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.